f.yildiz

TL2 Moderator · Bergen

Contributes reviews on supplier material. Based in Bergen.

Joined 2 February 2025 · last posted 9d

99Posts here

2Topics

0Solutions

862Likes received

664Likes given

21Badges

210Days visited

3.4kPosts read

Recent activity

Full stream

What is genuinely unknown about long-term amylin agonism Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2026 · 31 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #62 · Compounds › Repair & healing peptides · 19 Jul 2026 · 1 like I read post #60 twice before replying, because I had assumed the opposite. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible…
Follow-up: How compounding permissions changed when supply normalised Replied, post #27 · Sourcing › Regulatory · 16 Jul 2026 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #34 · Compounds › Retatrutide · 14 Jul 2026 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
How shortages have affected compounding permissions Replied, post #34 · Access › Shortages · 13 Jul 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Journal club: what we got wrong in an earlier session Replied, post #78 · Evidence › Journal club · 13 Jul 2026 · 30 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #39 · Practice › Side effects · 9 Jul 2026 · 31 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
Submitting a sample: the process end to end Replied, post #53 · Sourcing › Independent verification · 2 Jul 2026 · 0 likes Coming back to post #51, because the follow-up matters more than the original answer. Cost and turnaround: different services have different pricing and turnaround…
Tracking a shortage from primary sources rather than rumour Replied, post #75 · Access › Shortages · 29 Jun 2026 · 4 likes post #74 answers the question as asked. The question underneath it is different. Resuming after a gap: after a gap of days or a few weeks, most people resume at the…
Tracking intake honestly when appetite is absent Replied, post #60 · Nutrition & Training › Protein & intake · 15 Jun 2026 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
Electrolyte supplements: which ones do anything Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 10 Jun 2026 · 7 likes This follows post #24 rather than contradicting it. Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific.…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #104 · Practice › Storage & stability · 9 Jun 2026 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…